Literature DB >> 12105406

Improving sedation and analgesia in the critically ill.

G Park1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105406

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


× No keyword cloud information.
  4 in total

Review 1.  Remifentanil : a review of its analgesic and sedative use in the intensive care unit.

Authors:  Anna J Battershill; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment.

Authors:  Des Breen; Alexander Wilmer; Andrew Bodenham; Vagn Bach; Jan Bonde; Paul Kessler; Sven Albrecht; Soraya Shaikh
Journal:  Crit Care       Date:  2003-11-21       Impact factor: 9.097

3.  Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713].

Authors:  Bernd Muellejans; Angel López; Michael H Cross; César Bonome; Lachlan Morrison; Andrew J T Kirkham
Journal:  Crit Care       Date:  2003-11-20       Impact factor: 9.097

4.  Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497].

Authors:  Des Breen; Andreas Karabinis; Manu Malbrain; Rex Morais; Sven Albrecht; Inge-Lise Jarnvig; Pauline Parkinson; Andrew J T Kirkham
Journal:  Crit Care       Date:  2005-03-15       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.